Sumitomo Pharma America, Inc.
Clinical trials sponsored by Sumitomo Pharma America, Inc., explained in plain language.
-
Stem cell patch aims to slow vision loss in rare eye disease
Disease control Recruiting nowThis study tests a one-time injection of retinal sheets made from stem cells into the eye of 12 adults with retinitis pigmentosa, a genetic condition that causes progressive vision loss. The main goal is to see if the treatment is safe and tolerable. Participants are grouped by t…
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Tiny study tracks experimental drug's journey through the body
Knowledge-focused Recruiting nowThis study looks at how a new drug called DSP-5336 is absorbed, broken down, and removed from the body after a single dose. It involves 8 adults with blood cancers like leukemia or myeloma that have not responded to standard treatments. The goal is to understand the drug's metabo…
Phase: PHASE1 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 05:48 UTC